Posters & Publications MGX Presentation CSHL August 2024
Eyebrow
Two column section headline
-
Heading
Optional Icon Simple text simple text
Rich text heading
Simple text here.
Rich Text here.
- You can include stuff
- In lists
- Like this
Eyebrow
Text Left + Media Right
We combine our analytical expertise with our metagenomics-powered discovery platform to reveal novel cellular machinery sourced from otherwise unknown organisms. Our scientists mine our extensive, proprietary genome-resolved metagenomics database and rapidly develop their findings into highly efficient gene editing systems.
Heading
Headline
We combine our analytical expertise with our metagenomics-powered discovery platform to reveal novel cellular machinery sourced from otherwise unknown organisms. Our scientists mine our extensive, proprietary genome-resolved metagenomics database and rapidly develop their findings into highly efficient gene editing systems.
Card Headline
Our modular approach to engineering enables precise editing with high efficiency at a wide variety of genetic sites.
Card Headline
Our modular approach to engineering enables precise editing with high efficiency at a wide variety of genetic sites.
LatestNews
Description — Our modular approach to engineering enables precise editing with high efficiency at a wide variety of genetic sites.
-
09.14.24 -
Posters & Publications MGX Presentation ASGCT May 9 2024
05.10.24 Novel CRISPR Effectors and Reverse Transcriptases Discovered from Metagenomics Enable Extensive Remodeling of the Human Genome
-
Posters & Publications MGX Presentation ASGCT May 8 2024
05.10.24 Novel and efficient base editors engineered to comprehensively target the human genome
End of imgage grid
Heading
Headline
Description
-
Heading
Our modular approach to engineering enables precise editing with high efficiency at a wide variety of genetic sites.
-
Heading
Our modular approach to engineering enables precise editing with high efficiency at a wide variety of genetic sites.
-
Heading
Our modular approach to engineering enables precise editing with high efficiency at a wide variety of genetic sites.
Arrow Section
Section description
- 100 thousand
- Stat description
- 100 thousand
- Stat description
- 100 thousand
- Stat description
Heading
Pipeline
Discovery
PreClinical
Phase 1
Phase 2
Phase 3
Partner
Heading
Description
Discovery
PreClinical
Phase 1
Phase 2
Phase 3
-
-
Target system unknown, targeting Target, Discovery 50% completed, in partnership with a pharmaceutical research company
Partner info
Description
-